Dialectic Therapeutics

Stage event at MassChallenge event

MassChallenge Makes Dallas Its Second U.S. Headquarters

by | Sep 30, 2026
Four years after arriving at Pegasus Park, the Boston-based accelerator is adding health and security accelerators and founder clinics, backed by a renewed two-year grant from Lyda Hill Philanthropies.
MORE►
CPRIT Is Funding the Development of Products That Fight Cancer
by | Sep 6, 2022
The Cancer Prevention & Research Institute of Texas has provided more than $3.1 billion in funding toward the development of cancer-fighting therapeutics, devices, diagnostics, and tools since 2010. It's now issued a call for startups and early-stage companies to apply for product development research grants for the 2023 fiscal year. “CPRIT’s mission is to invest in the research prowess of Texas institutions while expediting breakthroughs in cancer cures and prevention,” CEO Wayne Roberts said last May.
MORE►
Dialectic
Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award
by | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE►